Select patients for therapy based on an FDA-approved companion diagnostic test.
Metastatic Breast Cancer
Phesgo™ is indicated for use in combination with docetaxel for the treatment of adult patients with HER2-positive metastatic breast cancer (MBC) who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Select patients for therapy based on an FDA-approved companion diagnostic test.
See prescribing information.
Posted on 11/19/2020
